Sucampo Pharma (SCMP) Announces Completion of $275M R-Tech Ueno Acquisition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Sucampo Completes Acquisition of R-Tech Ueno
December 7, 2015 6:45 AM ESTImmediately Accretive to Revenue, Earnings and Operating Cash Flows
Delivers Greater Manufacturing and Supply Chain Control
Expands Sucampo's Product Pipeline
ROCKVILLE, Md., Dec. 7, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ: SCMP), a global biopharmaceutical company, today announced the completion of its acquisition of R-Tech Ueno (TSE:4573:JP) and all remaining outstanding shares. Sucampo acquired R-Tech Ueno for 32.8 billion Japanese Yen (JPY), or approximately $275 million.
"We believe that, through this immediately accretive... More
